Microperymetry
Diagnostic TestMicroperimetry is a procedure to assess retinal sensitivity while fundus is directly examined; it enables exact correlation between macular pathology and corresponding functional abnormality.
NCT Number: NCT03701542
To examine the relationship between morphological and functional results in eyes after vitrectomy due to the full thickness macular hole (FTMH).
Looking for future studies?
Notify MeAll sexes
Observational
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The diagnosed full thickness macular hole and psuedophakia.
Exclusion criteria
macular pseudohole, non-full thickness macular hole, retinal detachment, other ocular comorbidities.
Microperimetry is a procedure to assess retinal sensitivity while fundus is directly examined; it enables exact correlation between macular pathology and corresponding functional abnormality.
The M-chart (Inami Co., Tokyo, Japan) is a diagnostic tool developed by Matsumoto to quantify the degree of metamorphopsia in patients with macular diseases.
Time frame: 1 to 6 months
Acuity is a measure of visual performance. The eye exam seeks to find the prescription that will provide the best corrected visual performance achievable
Time frame: 1 to 6 months
The Amsler grid, consisting of evenly spaced horizontal and vertical lines, has been widely used since 1947 to test the metamorphopsia.
Time frame: 1 to 6 months
Quantitative thickness measurements derived from the "fast macular scan" algorithm report retinal thickness at several locations including the center point, central subfield, and 4 inner and 4 outer zones of the macula.
Time frame: 1 to 6 months
Microperimetry is a procedure to assess retinal sensitivity while fundus is directly examined; it enables exact correlation between macular pathology and corresponding functional abnormality. It is a psychophysical method which is rapid, safe and non-invasive.
Medical University of Lublin
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06915948
Eye Diseases, Macular Holes
Palakkad, Kerala, India
View Trial DetailsNCT05171621
Epiretinal Membrane, Eye Diseases
Cardiff, United Kingdom
View Trial DetailsNCT02010138
Eye Diseases, Macular Holes
Seoul, South Korea
View Trial DetailsNCT05860985
Epiretinal Membrane, Eye Diseases
Leuven, Vlaams-Brabant, Belgium
View Trial Details